BXRX insider filings
Baudax Bio, Inc. — 32 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-12-19. Screen BXRX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BXRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Baudax Bio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-12-19 | 4 | HENWOOD GERALDINE — President and CEO, Director | Purchase (P): 1,200 @ $2.55 | EDGAR |
| 2022-06-17 | 4 | CHURCHILL WINSTON J — Director | Grant/award (A): 39,473 @ $0 | EDGAR |
| 2022-06-17 | 4 | Dilmore Jillian — Corporate Controller/Secretary | Grant/award (A): 15,467 @ $0 | EDGAR |
| 2022-06-17 | 4 | Baskies Arnold M — Director | Grant/award (A): 39,473 @ $0 | EDGAR |
| 2022-06-17 | 4 | Weisman Wayne — Director | Grant/award (A): 39,473 @ $0 | EDGAR |
| 2022-06-17 | 4 | Ashton William — Director | Grant/award (A): 39,473 @ $0 | EDGAR |
| 2022-06-17 | 4 | Drechsler Andrew T — Director | Grant/award (A): 39,473 @ $0 | EDGAR |
| 2022-06-17 | 4 | HENWOOD GERALDINE — President and CEO, Director | Grant/award (A): 39,473 @ $0 | EDGAR |
| 2021-12-23 | 4 | HENWOOD GERALDINE — President and CEO, Director | Tax withholding (F): 18,636 @ $0.31 · Grant/award (A): 821,168 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | HENWOOD GERALDINE — President and CEO, Director | Tax withholding (F): 9,155 @ $0.35 | EDGAR |
| 2021-09-23 | 4 | HENWOOD GERALDINE — President and CEO, Director | Purchase (P): 8,200 @ $0.59 | EDGAR |
| 2021-08-31 | 4 | CHURCHILL WINSTON J — Director | Purchase (P): 100,000 @ $0.63 | EDGAR |
| 2021-08-23 | 4 | Casten Richard S — Chief Financial Officer | Purchase (P): 50,000 @ $0.51 | EDGAR |
| 2021-06-08 | 4 | CHURCHILL WINSTON J — Director | Purchase (P): 15,000 @ $0.78 · Purchase (P): 10,000 @ $0.78 | EDGAR |
| 2021-05-17 | 4 | Casten Richard S — Chief Financial Officer | Purchase (P): 25,000 @ $0.79 | EDGAR |
| 2021-05-13 | 4 | Baskies Arnold M — Director | Purchase (P): 10,000 @ $0.82 | EDGAR |
| 2021-05-10 | 4 | HENWOOD GERALDINE — President and CEO, Director | Purchase (P): 6,000 @ $0.83 | EDGAR |
| 2021-04-08 | 4 | CHURCHILL WINSTON J — Director | Grant/award (A): 56,452 @ $0 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2021-04-08 | 4 | Baskies Arnold M — Director | Grant/award (A): 56,452 @ $0 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2021-04-08 | 4 | Weisman Wayne — Director | Grant/award (A): 56,452 @ $0 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2021-04-08 | 4 | Ashton William — Director | Grant/award (A): 56,452 @ $0 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2021-04-08 | 4 | Drechsler Andrew T — Director | Grant/award (A): 56,452 @ $0 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2021-04-08 | 4 | ALTOMARI ALFRED — Director | Grant/award (A): 56,452 @ $0 · Grant/award (A): 83,333 (derivative) @ $0 | EDGAR |
| 2021-03-16 | 4 | Casten Richard S — Chief Financial Officer | Purchase (P): 25,000 @ $1.41 | EDGAR |
| 2021-03-10 | 4 | Casten Richard S — Chief Financial Officer | Grant/award (A): 15,000 @ $0 · Grant/award (A): 85,000 @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 255,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | HENWOOD GERALDINE — President and CEO, Director | Grant/award (A): 65,435 @ $0 | EDGAR |
| 2021-01-20 | 4 | Lake Ryan David — Chief Financial Officer | Grant/award (A): 5,000 @ $0 · Grant/award (A): 20,000 @ $0 · Tax withholding (F): 26,658 @ $1.30 · Grant/award (A): 23,077 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-12-09 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 15,064 @ $1.14 · Tax withholding (F): 4,845 @ $1.14 | EDGAR |
| 2020-12-09 | 4 | HENWOOD GERALDINE — President and CEO, Director | Tax withholding (F): 11,732 @ $1.14 · Tax withholding (F): 71,283 @ $1.14 | EDGAR |
| 2020-11-24 | 4 | ALTOMARI ALFRED — Director | Purchase (P): 5,000 @ $1.06 | EDGAR |
| 2020-08-21 | 4 | Baskies Arnold M — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2020-08-21 | 4 | Drechsler Andrew T — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
Recent 8-K events — Baudax Bio, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-02-28 | 8-K | 1.03 — Bankruptcy or Receivership | EDGAR |
| 2023-12-13 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-11-15 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-10-25 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-10-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-07 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BXRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs